Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

0.9401
+0.08009.30%
Volume:276.17K
Turnover:252.41K
Market Cap:14.04M
PE:-0.57
High:0.9700
Open:0.8800
Low:0.8600
Close:0.8601
52wk High:4.70
52wk Low:0.8375
Shares:14.94M
Float Shares:12.00M
Volume Ratio:0.71
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-4.36
PE(LYR):-0.60

Loading ...

Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Correspondence

Form CORRESP - Correspondence
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities